Regulation of murine B cell growth and differentiation by CD30 ligand

No abstract is available for this paper.

• Publication year

  1995

• Venue

  European Journal of Immunology

• Publication date

  1995-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.1830250805PMID 7664777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• T cell clones from an X-linked hyper-immunoglobulin (IgM) patient induce IgE synthesis in vitro despite expression of nonfunctional CD40 ligand

  1994cited by this paper
• Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV‐1‐regulated protein gp34.

  1994cited by this paper
• The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death.

  1994cited by this paper
• Humoral immune responses in CD40 ligand-deficient mice

  1994cited by this paper
• The role of CD40 in the regulation of humoral and cell-mediated immunity.

  1994cited by this paper
• Recombinant CD40 ligand exerts potent biologic effects on T cells.

  1994cited by this paper
• The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration.

  1994cited by this paper
• Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines.

  1994cited by this paper
• Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines

  1994cited by this paper
• gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory

  1994cited by this paper
• CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF.

  1993cited by this paper
• Molecular cloning of a ligand for the inducible T cell gene 4‐1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor

  1993cited by this paper
• CD40 ligand is a T cell growth factor

  1993cited by this paper
• Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM

  1993cited by this paper
• Fas transduces activation signals in normal human T lymphocytes

  1993cited by this paper
• CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome

  1993cited by this paper
• Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor.

  1993cited by this paper
• Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.

  1993cited by this paper
• The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2.

  1993cited by this paper
• Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokines

  1993cited by this paper
• Molecular and biological characterization of a murine ligand for CD40.

  1992cited by this paper
• Molecular and biological characterization of a murine ligand for CD40

  1992cited by this paper
• Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion

  1992cited by this paper
• Soluble forms of CD40 inhibit biologic responses of human B cells.

  1992cited by this paper
• A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells.

  1992cited by this paper
• Activated human T cells express a ligand for the human B cell‐associated antigen CD40 which participates in T cell‐dependent activation of B lymphocytes

  1992cited by this paper
• A novel IL‐1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types.

  1991cited by this paper
• Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein.

  1991cited by this paper
• Regulation of T cell proliferation by IL-7.

  1990cited by this paper
• Cytokine receptors and B cell functions. I. Recombinant soluble receptors specifically inhibit IL-1- and IL-4-induced B cell activities in vitro.

  1990cited by this paper
• A Short Polypeptide Marker Sequence Useful for Recombinant Protein Identification and Purification

  1988cited by this paper
• Stimulation of B-cell progenitors by cloned murine interleukin-7

  1988cited by this paper
• Regulation of murine T cell proliferation by B cell stimulatory factor-1.

  1987cited by this paper
• Biochemical characterization and biosynthesis of the Ki-1 antigen in Hodgkin-derived and virus-transformed human B and T lymphoid cell lines.

  1987cited by this paper
• The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.

  1985cited by this paper
• Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells

  1982cited by this paper

• Pathobiological link between CD30 and abnormal lymphocytes in adult T-cell leukemia/lymphoma

  2025cites this paper
• CD30 plays a role in T‐dependent immune response and T cell proliferation

  2023cites this paper
• Elevated CD153 Expression on Aged T Follicular Helper Cells is Vital for B cell Responses

  2023cites this paper
• CD30-targeted therapy induces apoptosis of inflammatory cytokine-stimulated synovial fibroblasts and ameliorates collagen antibody-induced arthritis in mice

  2022cites this paper
• Predictive tools to determine risk of infection in kidney transplant recipients

  2020cites this paper
• Immunology of Melanoma

  2020cites this paper
• Chronic CD30 signaling in B cells results in lymphomagenesis by driving the expansion of plasmablasts and B1 cells.

  2019cites this paper
• Reverse Signaling of Tumor Necrosis Factor Superfamily Proteins in Macrophages and Microglia: Superfamily Portrait in the Neuroimmune Interface

  2019cites this paper
• Die humorale Immunantwort

  2018cites this paper
• Markers of Immune Activation and Inflammation, and Non-Hodgkin Lymphoma: A Meta-Analysis of Prospective Studies

  2018cites this paper
• ATVB Distinguished Scientist Award: How Costimulatory and Coinhibitory Pathways Shape Atherosclerosis

  2017cites this paper
• Serum sCD30: A promising biomarker for predicting the risk of bacterial infection after kidney transplantation

  2017cites this paper
• Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis

  2017cites this paper
• Novosti u dijagnostici i liječenju hodgkinovog limfoma

  2016cites this paper
• Investigating the in vivo requirements for the generation and survival of CD4⁺ memory T cells

  2016cites this paper
• Requirement of CD30 expression on CD4 T cells in the pathogenesis of experimental autoimmune encephalomyelitis.

  2016cites this paper
• Differentiation of protective B cell responses in chronic viral infection

  2016cites this paper
• ADCs Approved for Use: Brentuximab Vedotin

  2016cites this paper
• Analyse genetischer Läsionen im Hodgkin-Lymphom und einem Kombinationslymphom sowie Charakterisierung humaner CD30-positiver B-Zellen

  2015cites this paper
• CD30 ligand is a new therapeutic target for central nervous system autoimmunity.

  2015cites this paper
• Characterization of CD30/CD30L+ Cells in Peripheral Blood and Synovial Fluid of Patients with Rheumatoid Arthritis

  2015cites this paper
• Patterns of T cell co-stimulation and co-inhibition in tumor microenvironment conditions, in vitro

  2015cites this paper
• Innate patterning of the immune response to Marek's disease virus (MDV) during pathogenesis and vaccination

  2015cites this paper
• Brentuximab: a major advance in treatment of CD30-positive malignancies

  2015cites this paper
• CD30 in systemic mastocytosis.

  2014cites this paper
• Correlation of Gene Expression and Genome Mutation in Single B-Cells

  2013cites this paper
• CD30: from basic research to cancer therapy

  2013cites this paper
• Regulating atherosclerosis via costimulatory and coinhibitory pathways

  2013cites this paper
• TNF and TNF Receptor Superfamily Members in HIV infection: New Cellular Targets for Therapy?

  2013cites this paper
• Regulation of immune responses in atherosclerosis

  2013cites this paper
• Interference of the CD30–CD30L Pathway Reduces Atherosclerosis Development

  2012cites this paper
• CD30: an important new target in hematologic malignancies

  2011cites this paper
• CD30 Discriminates Heat Shock Protein 60-Induced FOXP3+CD4+ T Cells with a Regulatory Phenotype

  2010cites this paper
• Regulatory Phenotype T Cells with a + CD 4 + 60-Induced FOXP 3 CD 30 Discriminates Heat Shock Protein

  2010cites this paper
• Early divergent B cell differentiation during antibody responses

  2009cites this paper
• Therapeutic targets of the TNF superfamily

  2009cites this paper
• Targeting CD30/CD30L in oncology and autoimmune and inflammatory diseases.

  2009cites this paper
• CD30 supports lung inflammation.

  2008cites this paper
• A Novel Role of CD30L/CD30 Signaling by T-T Cell Interaction in Th1 Response against Mycobacterial Infection1

  2008cites this paper
• Generierung und Charakterisierung von spezifischen T-Zell-Antworten gegen Pilz- und Tumorantigene

  2008cites this paper
• This information is current as Mycobacterial Infection T-T Cell Interaction in Th 1 Response against A Novel Role of CD 30 L / CD 30 Signaling by Yoshikai

  2008cites this paper
• Pathways of T-cell costimulation

  2007cites this paper
• Soluble CD30 serum level--an adequate marker for allograft rejection of solid organs?

  2007cites this paper
• A New Role of CTLA-4 on B Cells in Thymus-Dependent Immune Responses In Vivo1

  2007cites this paper
• Deciphering CD30 ligand biology and its role in humoral immunity

  2006cites this paper
• Tumor Necrosis Factor/Tumor Necrosis Factor Receptor Family Members That Positively Regulate Immunity

  2006cites this paper
• T-cell regulation in juvenile idiopathic arthritis

  2006cites this paper
• OCCURRENCE OF CD30 ANTIGEN ON TISSUES AND CELLS OTHER THAN LYMPHOID ORIGIN. A STUDY OF HUMAN FETAL SKIN IN 8, 10, AND 12 GESTATIONAL WEEKS

  2006cites this paper
• Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD)

  2005influential citation
• OCCURRENCE OF CD30 ANTIGEN ON TISSUES AND CELLS OTHER THAN LYMPHOID ORIGIN. A STUDY OF HUMAN FETAL SKIN IN 8 TH , 10 TH , AND 12 TH GESTATIONAL WEEKS

  2005cites this paper
• CD30/CD30 Ligand (CD153) Interaction Regulates CD4+ T Cell-Mediated Graft-versus-Host Disease1

  2004cites this paper
• Role of T-Cell Costimulation and Regulatory Cells in Allogeneic Hematopoietic Cell Transplantation

  2004cites this paper
• Molecular cloning and characterization of chicken tumor necrosis factor (TNF)-superfamily ligands, CD30L and TNF-related apoptosis inducing ligand (TRAIL).

  2004cites this paper
• Molecular cytogenetic studies in the Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma

  2004cites this paper
• CD30 Is Involved in Inhibition of T-Cell Proliferation by Hodgkin’s Reed-Sternberg Cells 1

  2004cites this paper
• Graft-versus-Host Disease T Cell-Mediated + Regulates CD4 CD30/CD30 Ligand (CD153) Interaction

  2004cites this paper
• Expression and a role of CD30 in regulation of T-cell activity

  2003cites this paper
• CD30-Mediated Regulation of Cell Adhesion Molecule Expression on Murine T Cells

  2003cites this paper
• Levels of soluble CD30 in cord blood and peripheral blood during childhood are not correlated with the development of atopic disease or a family history of atopy

  2003cites this paper
• Viruses and the TNF-related cytokines, an evolving battle.

  2003cites this paper
• Hodgkin’s Lymphoma and CD30 Signal Transduction

  2003cites this paper
• Critical roles of CD30/CD30L interactions in murine autoimmune diabetes

  2003cites this paper
• Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

  2003cites this paper
• Death and survival: viral regulation of TNF signaling pathways.

  2003cites this paper
• Cytotoxic Signal Transmission Pathways via TNF Family Receptors

  2002cites this paper
• Microarray analysis of B-cell stimulation.

  2002cites this paper
• T-Cell Costimulatory Pathways Relevant to Transplant Rejection and Tolerance

  2002cites this paper
• Separation and mapping of multiple genes that control IgE level in Leishmania major infected mice

  2002cites this paper
• Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: A soluble, secreted CD30 homologue

  2002cites this paper
• Regulation of lymphocyte clustering by CD30-mediated ICAM-1 up-regulation.

  2002cites this paper
• Cytotoxic signal transduction pathways via TNF family receptors.

  2002cites this paper
• Molecular Identification of IgE-Dependent Histamine-Releasing Factor as a B Cell Growth Factor1

  2001cites this paper
• Growth Factor Histamine-Releasing Factor as a B Cell Molecular Identification of IgE-Dependent

  2001cites this paper
• The role of CD30 in atopic disease

  2001cites this paper
• Tetracyclines inhibit activated B cell function.

  2001cites this paper
• CD30: CD30 Ligand Interactions in the Immune Response

  2001cites this paper
• Autocrine Growth Regulation of CD30 Ligand in CD30-Expressing Reed-Sternberg Cells: Distinction Between Hodgkin's Disease and Anaplastic Large Cell Lymphoma

  2000cites this paper
• Characterization of the CD30L Binding Domain on the Human CD30 Molecule Using Anti-CD30 Antibodies

  2000cites this paper
• Environmental Factors Favoring the Allergen‐specific Th2 Response in Allergic Subjects

  2000cites this paper
• Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes

  2000cites this paper
• APRIL and TALL-1 and receptors BCMA and TACI: system for regulating humoral immunity

  2000cites this paper
• CD30 in normal and neoplastic cells.

  1999cites this paper
• Pathway Programmed Cell Death Via a Bcl-2-Sensitive Selection in the Thymus and Mediates CD 30 Overexpression Enhances Negative

  1999cites this paper
• Significance of CD30-positive lymphocytes in livers in primary biliary cirrhosis.

  1999cites this paper
• CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway.

  1999cites this paper
• Expression of CD30 ligand (CD153) on murine activated T cells.

  1999cites this paper
• BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth

  1999cites this paper
• CD30: expression and function in health and disease.

  1998cites this paper
• Overview of Germinal Center Function and Structure in Normal and Genetically Engineered Mice

  1998cites this paper
• Molecular and cellular mechanisms of T lymphocyte apoptosis.

  1998cites this paper
• CD40 Ligand Knockout Mice

  1998cites this paper
• Handbook of Imune Response Genes

  1998cites this paper
• Molecular regulation of human IgE synthesis

  1997cites this paper
• Cognate T cell help for CD40-deficient B cells induces c-myc RNA expression, but DNA synthesis requires an additional signal through surface Ig.

  1997cites this paper
• CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2.

  1997cites this paper
• Reciprocal regulation of CD30 expression on CD4+ T cells by IL-4 and IFN-gamma.

  1997cites this paper
• Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily.

  1997cites this paper
• Reverse signaling via CD30 ligand.

  1996cites this paper
• A CD30 responsive element in the germline epsilon promoter that is distinct from and inhibitory to the CD40 response element.

  1996cites this paper
• A CD30 responsive element in the germline ϵ promoter that is distinct from and inhibitory to the CD40 response element

  1996cites this paper